A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome ® in Healthy Subjects

Condition:   Bioequivalence Interventions:   Drug: Amphotericin B liposome for injection;   Drug: AmBisome® Sponsor:   CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abelcet | Research | Study